Hridesh Petrochemical And Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 10.00 K
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 84.46%
- Ebitda 84.46%
- Net Worth -10.63%
- Total Assets %
About Hridesh Petrochemical And Pharma
Hridesh Petrochemical And Pharma Private Limited (HPAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2017 (Seven years and 11 months 16 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Rakesh Rajput and Vishal Gurav serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909MH2017PTC292257
- Company No.
292257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hridesh Petrochemical And Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Rajput  | Director | 03-Mar-2022 | Current |
| Vishal Gurav | Director | 03-Mar-2022 | Current |
Financial Performance of Hridesh Petrochemical And Pharma.
Hridesh Petrochemical And Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 84.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hridesh Petrochemical And Pharma?
In 2018, Hridesh Petrochemical And Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mangalaya Infrastructure Private LimitedRakesh Rajput is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hridesh Petrochemical And Pharma?
Unlock and access historical data on people associated with Hridesh Petrochemical And Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hridesh Petrochemical And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hridesh Petrochemical And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
